Navigation Links
Issuer Ratings, Recognitions, Positive Clinical Results, and Quarterly Dividends - Research Report on Pfizer, UnitedHealth, Merck, Gilead, and Bristol-Myers
Date:9/20/2013

o, Fitch anticipates Pfizer will generate strong free cash flow and maintain solid liquidity during the intermediate term, and continue to aggressively deploy cash towards acquisitions and share repurchases. The Full Research Report on Pfizer Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/d702_PFE]

--

UnitedHealth Group Inc. Research Report

On September 13, 2013, UnitedHealth Group Inc. (UnitedHealth) announced that it was named to the Dow Jones Sustainability North America Index (DJSI NA) and the Dow Jones Sustainability World Index (DJSI W). According to UnitedHealth, it was recognized among the leading companies worldwide for economic, environmental, and social excellence and sustainability performance, with a strong focus on long-term shareholder value. In addition, UnitedHealth ranked first in health care providers and services industry sector for corporate citizenship and philanthropy, partnerships toward sustainable health care, codes of conduct and compliance, and operational eco-efficiency. The Full Research Report on UnitedHealth Group Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/73e5_UNH]

--

Merck & Co., Inc. Research Report

On September 17, 2013, Merck & Co., Inc. (Merck) announced that the Company was named as one of the Working Mother 100 Best Companies for 2013, which recognizes companies for their commitment to progressive workplace programs, including female representation, compensation, child care, flexibility, time off and leave, family friendly programs, and company culture. '/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Successful Clinical Trials, Recognitions, Enrollment in Studies, Product Launches, and Strategic Announcements - Research Report on Boston Scientific, Gilead, Abbott, Actavis, and Covidien
2. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
3. Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry
4. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
5. Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
6. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
7. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
8. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
9. Scioderm Announces Positive Phase II Data of Topical SD-101 on Wound Closure and Reduction of Lesions and Blisters in Children with Epidermolysis Bullosa (EB)
10. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
11. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Denmark and ATLANTA ... 31, 2015 the US Food and Drug Administration (FDA) cleared ... Depressive Disorder in adult patients who have failed to receive ... TMS is a non-invasive technique for stimulating neural tissue in ... Major Depressive Disorder. The procedure has been proven safe and ...
(Date:8/28/2015)... The report "Eubiotics Market by Type (Probiotics, Prebiotics, ... Aquaculture), & by Region ( North America , ... and Rest of the World) - Global Trends and Forecast ... was valued at USD 4.62 Billion in 2014 and is ... CAGR of 7.4% from 2015 to 2020. ...
(Date:8/28/2015)... , August 28, 2015 The ... reach USD 49.12 billion by 2020, growing at a ... a new report by Grand View Research, Inc. Monitoring ... of 49.7% from 2014 to 2020.      ... population along with rising incidences of chronic diseases such ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5
...  Results from the combined analysis of two European ... 3rd European Lung Cancer Conference in Geneva, Switzerland. ... samples from advanced non-squamous non-small cell lung cancer ... plus erlotinib.  Results showed that the VeriStrat test ...
... (NASDAQ: STAA ), the leading developer, manufacturer and ... that the total number of its Visian® ICL implants in ... have been the Visian Toric ICL which is approved in ... of the U.S. The Company will highlight the benefits of ...
Cached Medicine Technology:VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer 2VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer 3STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 2STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 3STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 4STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 5
(Date:8/28/2015)... ... August 28, 2015 , ... The Quatela Center for Plastic Surgery ... first and only nonsurgical product approved by the Food and Drug Administration to eliminate ... and Dr. William Koenig are among the premier cosmetic surgeons in Rochester ...
(Date:8/28/2015)... IL (PRWEB) , ... August 28, 2015 , ... Mendon, ... evening of good music and good people, all for a good cause. In its ... 30th, 2015, sponsored once more by Best Drug Rehabilitation. The “Mission” of “Music With ...
(Date:8/28/2015)... ... August 28, 2015 , ... Healthpointe clinics throughout Southern ... sea diving. The act of recreational diving exposes the body to extreme ... is vital that all recreational and professional divers undergo regular comprehensive scuba physicals. ...
(Date:8/28/2015)... ... August 28, 2015 , ... The newest therapy to receive ... for general use any time soon, according to educational website Surviving Mesothelioma. Click ... received orphan drug designation for mesothelioma last week from the FDA, will now head ...
(Date:8/28/2015)... ... August 28, 2015 , ... United ... to welcome TJS Insurance Group as its newest Partner Firm. Founded in 1924 ... and keeps them focused on their goals. Within the past 10 years, TJS ...
Breaking Medicine News(10 mins):Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:Healthpointe Now Offering Scuba Physicals 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3
... Philadelphia, 11 December 2008 An implantable hemodynamic monitor ... large subgroup of patients with heart failurethose with diastolic ... Journal of Cardiac Failure ( http://www.onlinejcf.com/ ), ... M.D., of Medical University of South Carolina, Charleston, the ...
... a goal of all European health care systems. Despite ... still very much at risk during the perinatal period, ... The European Perinatal Health Report released by the EURO-PERISTAT ... to date and takes a new approach to health ...
... year from infectious diseases, despite the availability of ... penicillin to treat bacterial infections, along with the ... such as polio and smallpox, achieved great reductions ... spectacular advances in medical imaging combined with mathematical ...
... in Multiple States, Lockheed Martin Presents Example of How ... , , NASHVILLE, Tenn., ... provider of managed care market intelligence, finds that with ... with carriers across the country to provide benefits to ...
... Dean bring lessons learned from California reform debate to ... , WASHINGTON, Dec. 11 Two ... Catholic Healthcare West (CHW) President / CEO Lloyd Dean ... Bodaken -- are founding members of Health CEOs for ...
... Wound Management,Technologies, Inc., (OTC Bulletin Board: WNDM), ... of BioPharma Management Technologies, Inc.,a company that has ... "While we have been focusing this year ... also have been working,to expand our current product ...
Cached Medicine News:Health News:Implantable monitor may help in managing diastolic heart failure 2Health News:Comparable data on maternal and infant in Europe available for the first time 2Health News:Comparable data on maternal and infant in Europe available for the first time 3Health News:Mathematical models of adaptive immunity 2Health News:Mathematical models of adaptive immunity 3Health News:Employer Vantage From HealthLeaders-InterStudy Provides a Snapshot of Both Self- and Fully-Insured Health Benefits to Help Pharmaceutical and Diagnostic Manufacturers Identify Business Opportunities 2Health News:Employer Vantage From HealthLeaders-InterStudy Provides a Snapshot of Both Self- and Fully-Insured Health Benefits to Help Pharmaceutical and Diagnostic Manufacturers Identify Business Opportunities 3Health News:California Health Industry Leaders Help Launch National CEO Coalition for Health Reform 2Health News:California Health Industry Leaders Help Launch National CEO Coalition for Health Reform 3Health News:California Health Industry Leaders Help Launch National CEO Coalition for Health Reform 4Health News:California Health Industry Leaders Help Launch National CEO Coalition for Health Reform 5Health News:Wound Management Technologies, Inc. Announces Negotiations to Acquire BioPharma Management Technologies, Inc. 2Health News:Wound Management Technologies, Inc. Announces Negotiations to Acquire BioPharma Management Technologies, Inc. 3